Homburger advised Addex Therapeutics Ltd on new PIPE transaction
On April 5, 2023, allosteric modulation company Addex Therapeutics Ltd in Plan-les-Ouates, Geneva (SIX: ADXN) announced that it has completed an equity financing transaction with a healthcare-focused institutional investor, pursuant to which Addex agreed to sell 7,999,998 shares in the form of 1,333,333 American Depositary Shares («ADSs») at a gross purchase price of USD 0.95 …
Continue reading “Homburger advised Addex Therapeutics Ltd on new PIPE transaction”
Homburger advises Zürcher Kantonalbank on the issuance of its inaugural CHF 425 m Bail-in Bonds
On April 5, 2023, Zürcher Kantonalbank priced its inaugural CHF 425 m Bail-in Bond issuance. ZKB’s Bail-in Bonds are novel instruments which have been designed and issued on the basis of a new legal framework allowing Cantonal Banks to issue Total-Loss-Absorbing-Capacity (TLAC) Bonds. In the event that FINMA orders the partial or complete reduction of …
Homburger advised Implenia on the acquisition of Wincasa
On March 30, 2023, Implenia AG (SIX: IMPN), Switzerland’s leading real estate and construction service provider, announced that it had agreed to purchase Wincasa AG for CHF 171.6 m from Swiss Prime Site AG (SIX: SPSN). Wincasa is the leading Swiss real estate service provider with more than 250,000 managed properties, CHF 81 bn in …
Continue reading “Homburger advised Implenia on the acquisition of Wincasa”
Homburger advises Clear Channel on the successful closing of the sale of its Swiss business to TX Group
On March 31, 2023, Clear Channel Outdoor Holdings, Inc. (NYSE: CCO), a global out-of-home advertising company, announced that it has completed the sale of its business in Switzerland to Goldbach Group AG, an affiliate of TX Group AG, for CHF 86.0 m.
Homburger advises Solenis on the acquisition of Diversey
On March 8, 2023, Solenis announced that it has entered into a definitive merger agreement under which Solenis will acquire Diversey in an all-cash transaction valued at an enterprise value of approximately USD 4.6 bn. Upon completion of the merger, Diversey will become a private company. Headquartered in Wilmington, Delaware, Solenis is a leading manufacturer …
Continue reading “Homburger advises Solenis on the acquisition of Diversey”
Homburger advised a syndicate of banks in connection with the financing of the acquisition of Norline AG
Homburger acted as counsel to Zürcher Kantonalbank as mandated lead arranger, agent, security agent and original lender as well as Credit Suisse (Switzerland) Ltd. and Migros Bank AG as mandated lead arrangers and original lenders in connection with the financing of the acquisition of Norline AG by private equity firm Argos Wityu. Norline AG is …
Homburger advised Nestlé on the issuance of an aggregate of USD 3 bn notes through an institutional (Rule 144A) offering in the United States of America
On March 14, 2023, Nestlé Holdings, Inc. successfully completed its issuance of USD 1 bn 5.250% Notes due 2026, USD 850 m 5.000% Notes due 2028, USD 500 m 4.950% Notes due 2030, and USD 650 m 4.850% Notes due 2033. The Notes are guaranteed by the Nestlé group’s Swiss parent company Nestlé S.A. The …
Homburger advised Credit Suisse on boardroom matters, contingency planning, transactional options, bank regulatory and corporate law aspects in connection with the various measures to support its liquidity situation and the merger of Credit Suisse with UBS
On March 19, 2023, Credit Suisse announced that Credit Suisse and UBS have entered into a merger agreement following the intervention of the Swiss Federal Department of Finance, the Swiss National Bank and the Swiss Financial Market Supervisory Authority FINMA. UBS will be the surviving entity upon closing of the merger transaction. Homburger advised Credit …
Homburger advised Roche Holding Ltd on the issuance of EUR 1.25 bn Bonds
On February 27, 2023, Roche Finance Europe B.V. issued EUR 1.25 bn Bonds guaranteed by Roche Holding Ltd.
Homburger advised Santhera on its financing through a private placement of shares and upsizing of existing financing
On February 28, 2023, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced a private placement of shares and an amendment of its existing financing with funds managed by Highbridge Capital Management, LLC, to provide up to CHF 22.2 m in aggregate, subject to certain milestones and conditions. In addition, Santhera issued 40 m shares in an …